Furthermore, in a phase 2 clinical trial addressing a patient group with type 2 diabetes and overweight/obesity, after 32 weeks of treatment, the cagrisema 2.4 mg group exhibited a more significant average weight loss compared to the cagrilintide 2.4 mg group or the group using semaglutide 2.4 mg alone, with reductions of 15.6%, 8.1%, and 5.1%, respectively
Missed dose: If you miss a dose, do not attempt to manage this independently
Increased Tooth Decay and Cavities : Patients are reporting a surprising increase in new cavities, even those with previously good oral hygiene habits
Seek urgent care for severe abdominal pain, repeated vomiting, rapid breathing, confusion, fainting, chest symptoms, or signs of severe dehydration
Symptomatic treatment may include antiemetics for nausea, though patients should consult with their healthcare provider before using over-the-counter options, as some products (such as those containing bismuth subsalicylate) may not be appropriate for all patients
